Home
About
FAQ
History (49)
Co-Principal Investigator
Extended preservation of the liver for clinical transplantation.
Central and Peripheral Determinants of Exercise Capacity in Heart Failure Patients With Preserved Ejection Fraction.
Adrenodoxin
Phase II Clinical Trial to Evaluate the Safety and Feasibility of Senolytic Therapy in Alzheimer’s Disease
See All 49 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Phase II Clinical Trial to Evaluate the Safety and Feasibility of Senolytic Therapy in Alzheimer’s Disease
Biography
contributor
Principal Investigator
Time
start date
2021-03-01
end date
2024-02-29
